Optimization of a Membrane Feeding Assay for Plasmodium vivax Infection in Anopheles albimanus

PLoS Neglected Tropical Diseases

Volumn 10, Issue 6, 2016, Pages

  Vallejo, Andrés F ^a   Rubiano, Kelly ^b   Amado, Andres ^b   Krystosik, Amy R ^c   Herrera, Sócrates ^b   Arévalo Herrera, Myriam ^b  

^a Malaria Vaccine and Drug Development Center (MVDC)   (Colombia)

^b Caucaseco Scientific Research Center   (Colombia)

^c KENT STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; ARTIFICIAL MEMBRANE;

ADULT; ANOPHELES; ANOPHELES ALBIMANUS; ARTICLE; DIAGNOSTIC PROCEDURE; DIRECT FEEDING ASSAY; FEMALE; GAMETOCYTE; HUMAN; IMMUNE RESPONSE; INCUBATION TIME; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; OOCYST; PARASITE TRANSMISSION; PARASITEMIA; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; POLYMERASE CHAIN REACTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ADOLESCENT; ANIMAL; ARTIFICIAL MEMBRANE; FEEDING BEHAVIOR; HOST PARASITE INTERACTION; MIDDLE AGED; MOSQUITO VECTOR; PARASITOLOGY; PHYSIOLOGY; TRANSMISSION; YOUNG ADULT;

ADOLESCENT; ADULT; ANIMALS; ANOPHELES; FEEDING BEHAVIOR; FEMALE; HOST-PARASITE INTERACTIONS; HUMANS; MALARIA, VIVAX; MALE; MEMBRANES, ARTIFICIAL; MIDDLE AGED; MOSQUITO VECTORS; PLASMODIUM VIVAX; YOUNG ADULT;

EID: 84979084541     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0004807     Document Type: Article

References (51)

1. WHOWorld Malaria Report 2014. Geneva: World Health Organization; 2014.
2. Doolan DL, Dobaño C, Baird JK, Acquired immunity to malaria. Clin Microbiol Rev. 2009;22(1):13–36. doi: 10.1128/CMR.00025-0819136431
3. Anstey NM, Douglas NM, Poespoprodjo JR, Price RN, Plasmodium vivax: clinical spectrum, risk factors and pathogenesis. Adv Parasitol. 2011;80:151–201.
4. Moorthy VS, Good MF, Hill AV, Malaria vaccine developments. The Lancet. 2004;363(9403):150–6. doi: 10.1016/S0140-6736(03)15267-1
5. Bousema T, Sutherland CJ, Churcher TS, Mulder B, Gouagna LC, Riley EM, et al. Human immune responses that reduce the transmission of Plasmodium falciparum in African populations. International Journal for Parasitology. 2011;41(3–4):293–300. Epub 2010/10/27. doi: 10.1016/j.ijpara.2010.09.00820974145; PubMed Central PMCID: PMCPmc3052432.
6. Coleman RE, Kumpitak C, Ponlawat A, Maneechai N, Phunkitchar V, Rachapaew N, et al. Infectivity of asymptomatic Plasmodium-infected human populations to Anopheles dirus mosquitoes in western Thailand. J Med Entomol. 2004;41(2):201–8. 15061279
7. Githeko A, Brandling-Bennett A, Beier M, Atieli F, Owaga M, Collins F, The reservoir of Plasmodium falciparum malaria in a holoendemic area of western Kenya. Trans R Soc Trop Med Hyg. 1992;86(4):355–8. 1359683
8. Targett G, Sinden R, Transmission blocking vaccines. Parasitol Today. 1985;1(6):155–8. 15275571
9. Nilsson SK, Childs LM, Buckee C, Marti M, Targeting human transmission biology for malaria elimination. PLoS Pathog. 2015;11(6):e1004871. doi: 10.1371/journal.ppat.100487126086192
10. Bousema T, Drakeley C, Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination. Clin Microbiol Rev. 2011;24(2):377–410. doi: 10.1128/CMR.00051-1021482730; PubMed Central PMCID: PMC3122489.
11. Reininger L, Billker O, Tewari R, Mukhopadhyay A, Fennell C, Dorin-Semblat D, et al. A NIMA-related protein kinase is essential for completion of the sexual cycle of malaria parasites. J Biol Chem. 2005;280(36):31957–64. doi: 10.1074/jbc.M50452320015970588.
12. Vallejo AF, Garcia J, Amado-Garavito AB, Arevalo-Herrera M, Herrera S, Plasmodium vivax gametocyte infectivity in sub-microscopic infections. Malaria journal. 2016;15(1):48. doi: 10.1186/s12936-016-1104-126822406; PubMed Central PMCID: PMC4730736.
13. Sattabongkot J, Maneechai N, Rosenberg R, Plasmodium vivax: gametocyte infectivity of naturally infected Thai adults. Parasitology. 1991;102(01):27–31.
14. LONGLEY RJ, SATTABONGKOT J, MUELLER I, Insights into the naturally acquired immune response to Plasmodium vivax malaria. Parasitology.1–17.
15. Vásquez-Jiménez JM, Arévalo-Herrera M, Henao-Giraldo J, Molina-Gómez K, Arce-Plata M, Vallejo AF, et al. Consistent prevalence of asymptomatic infections in malaria endemic populations in Colombia over time. Malaria Journal. 2016;15(1):1.
16. Vallejo AF, García J, Amado-Garavito AB, Arévalo-Herrera M, Herrera S, Plasmodium vivax gametocyte infectivity in sub-microscopic infections. Malaria Journal. 2016;15(1):1.
17. Vallejo AF, Martínez NL, González IJ, Arévalo-Herrera M, Herrera S, Evaluation of the loop mediated isothermal DNA amplification (LAMP) kit for malaria diagnosis in P. vivax endemic settings of Colombia. PLoS Negl Trop Dis. 2015;9(1):e3453. doi: 10.1371/journal.pntd.000345325569550
18. Vallejo AF, Chaparro PE, Benavides Y, Álvarez Á, Quintero JP, Padilla J, et al. High prevalence of sub-microscopic infections in Colombia. Malaria journal. 2015;14(1):1–7.
19. Sinden RE, Carter R, Drakeley C, Leroy D, The biology of sexual development of Plasmodium: the design and implementation of transmission-blocking strategies. Malaria Journal. 2012;11(70). doi: 10.1186/1475-2875-11-7022424474.
20. Armstrong JA, Bransby-Williams WR, The maintenance of a colony of Anopheles gambiae, with observations on the effects of changes in temperature. Bulletin of the World Health Organization. 1961;24:427–35. Epub 1961/01/01. 13684306; PubMed Central PMCID: PMCPmc2555905.
21. Nijhout MM, Carter R, Gamete development in malaria parasites: bicarbonate-dependent stimulation by pH in vitro. Parasitology. 1978;76(1):39–53. Epub 1978/02/01. 23512.
22. Blanford S, Chan BH, Jenkins N, Sim D, Turner RJ, Read AF, et al. Fungal pathogen reduces potential for malaria transmission. Science. 2005;308(5728):1638–41. Epub 2005/06/11. doi: 10.1126/science.110842315947189.
23. Scholte EJ, Knols BG, Takken W, Infection of the malaria mosquito Anopheles gambiae with the entomopathogenic fungus Metarhizium anisopliae reduces blood feeding and fecundity. Journal of Invertebrate Pathology. 2006;91(1):43–9. Epub 2005/12/27. doi: 10.1016/j.jip.2005.10.00616376375.
24. Arevalo-Herrera M, Solarte Y, Rocha L, Alvarez D, Beier JC, Herrera S, Characterization of Plasmodium vivax transmission-blocking activity in low to moderate malaria transmission settings of the Colombian Pacific coast. Am J Trop Med Hyg. 2011;84(2 Suppl):71–7. doi: 10.4269/ajtmh.2011.10-008521292881; PubMed Central PMCID: PMC3032493.
25. Bousema T, Sutherland CJ, Churcher TS, Mulder B, Gouagna LC, Riley EM, et al. Human immune responses that reduce the transmission of Plasmodium falciparum in African populations. Int J Parasitol. 2011;41(3):293–300.
26. Arevalo-Herrera M, Vallejo AF, Rubiano K, Solarte Y, Marin C, Castellanos A, et al. Recombinant Pvs48/45 antigen expressed in E. coli generates antibodies that block malaria transmission in Anopheles albimanus mosquitoes. PLoS One. 2015;10(3):e0119335. doi: 10.1371/journal.pone.011933525775466; PubMed Central PMCID: PMCPMC4361554.
27. Arevalo-Herrera M, Solarte Y, Yasnot MF, Castellanos A, Rincon A, Saul A, et al. Induction of transmission-blocking immunity in Aotus monkeys by vaccination with a Plasmodium vivax clinical grade PVS25 recombinant protein. Am J Trop Med Hyg. 2005;73(5 Suppl):32–7. 16291764.
28. Gamage-Mendis AC, Rajakaruna J, Carter R, Mendis KN, Transmission blocking immunity to human Plasmodium vivax malaria in an endemic population in Kataragama, Sri Lanka. Parasite Immunology. 1992;14(4):385–96. Epub 1992/07/01. 1437231.
29. Ramsey JM, Salinas E, Rodriguez MH, Acquired transmission-blocking immunity to Plasmodium vivax in a population of southern coastal Mexico. The American Journal of Tropical Medicine and Hygiene. 1996;54(5):458–63. Epub 1996/05/01. 8644898.
30. Arevalo-Herrera M, Solarte Y, Zamora F, Mendez F, Yasnot MF, Rocha L, et al. Plasmodium vivax: transmission-blocking immunity in a malaria-endemic area of Colombia. The American Journal of Tropical Medicine and Hygiene. 2005;73(5 Suppl):38–43. Epub 2005/11/18. 16291765.
31. Kaslow DC, Shiloach J, Production, Purification and Immunogenicity of a Malaria Transmission—Blocking Vaccine Candidate: TBV25H Expressed in Yeast and Purified Using N ickel—NTA Agarose. Biotechnology (N Y). 1994;12:494–9.
32. Sauerwein R, Bousema T, Transmission blocking malaria vaccines: Assays and candidates in clinical development. Vaccine. 2015.
33. Wu Y, Ellis RD, Shaffer D, Fontes E, Malkin EM, Mahanty S, et al. Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51. PLoS ONE. 2008;3(7):e2636. doi: 10.1371/journal.pone.000263618612426
34. Vaughan JA, Noden BH, Beier JC, Sporogonic development of cultured Plasmodium falciparum in six species of laboratory-reared Anopheles mosquitoes. The American journal of tropical medicine and hygiene. 1994;51(2):233–43. 8074258
35. Salas ML, Romero JF, Solarte Y, Olano V, Herrera MA, Herrera S, Development of sporogonic cycle of Plasmodium vivax in experimentally infected Anopheles albimanus mosquitoes. Mem Inst Oswaldo Cruz. 1994;89:115–9.
36. Collins WE, Warren M, Contacos PG, Skinner JC, Richardson BB, Kearse TS, The Chesson strain of Plasmodium vivax in Aotus monkeys and anopheline mosquitoes. The Journal of parasitology. 1980:488–97. 6771379
37. Arévalo-Herrera M, Vallejo AF, Rubiano K, Solarte Y, Marin C, Castellanos A, et al. Recombinant Pvs48/45 Antigen Expressed in E. coli Generates Antibodies that Block Malaria Transmission in Anopheles albimanus Mosquitoes. PLoS ONE. 2015;10(3):e0119335. doi: 10.1371/journal.pone.011933525775466
38. Shute PG, Maryon M, An Improved Technique for Staining Malaria Parasites with Giemsa Stain. Archives roumaines de pathologie experimentales et de microbiologie. 1963;22:887–94. Epub 1963/09/01. 14166976.
39. Nwakanma DC, Gomez-Escobar N, Walther M, Crozier S, Dubovsky F, Malkin E, et al. Quantitative detection of Plasmodium falciparum DNA in saliva, blood, and urine. The Journal of infectious diseases. 2009;199(11):1567–74. doi: 10.1086/59885619432544.
40. Shute GT, Wernsdorfer WH, McGregor I, The microscopic diagnosis of malaria. In: Malaria: principles and practice of malariology. 1: Churchill Livingstone; 1988. p. 781.
41. Rougemont M, Van Saanen M, Sahli R, Hinrikson HP, Bille J, Jaton K, Detection of four Plasmodium species in blood from humans by 18S rRNA gene subunit-based and species-specific real-time PCR assays. Journal of Clinical Microbiology. 2004;42(12):5636–43. Epub 2004/12/08. doi: 10.1128/jcm.42.12.5636-5643.200415583293; PubMed Central PMCID: PMCPmc535226.
42. Kone A, van de Vegte-Bolmer M, Siebelink-Stoter R, van Gemert GJ, Dara A, Niangaly H, et al. Sulfadoxine-pyrimethamine impairs Plasmodium falciparum gametocyte infectivity and Anopheles mosquito survival. International Journal of Parasitology. 2010;40(10):1221–8. doi: 10.1016/j.ijpara.2010.05.00420515695; PubMed Central PMCID: PMC3744324.
43. Herrera S, Vallejo AF, Quintero JP, Arevalo-Herrera M, Cancino M, Ferro S, Field evaluation of an automated RDT reader and data management device for Plasmodium falciparum/Plasmodium vivax malaria in endemic areas of Colombia. Malar J. 2014;13:87. doi: 10.1186/1475-2875-13-8724612585; PubMed Central PMCID: PMCPMC3995821.
44. Vallejo AF, Chaparro PE, Benavides Y, Alvarez A, Quintero JP, Padilla J, et al. High prevalence of sub-microscopic infections in Colombia. Malar J. 2015;14(1):201. doi: 10.1186/s12936-015-0711-625971594; PubMed Central PMCID: PMC4438632.
45. Vallejo AF, Martinez NL, Gonzalez IJ, Arevalo-Herrera M, Herrera S, Evaluation of the loop mediated isothermal DNA amplification (LAMP) kit for malaria diagnosis in P. vivax endemic settings of Colombia. PLoS Negl Trop Dis. 2015;9(1):e3453. doi: 10.1371/journal.pntd.000345325569550; PubMed Central PMCID: PMCPMC4287555.
46. Karl S, Davis TM, St-Pierre TG, A comparison of the sensitivities of detection of Plasmodium falciparum gametocytes by magnetic fractionation, thick blood film microscopy, and RT-PCR. Malaria Journal. 2009;8:98. Epub 2009/05/13. doi: 10.1186/1475-2875-8-9819432971; PubMed Central PMCID: PMCPmc2689255.
47. Vallejo AF, Garcìa J, Amado-Garavito AB, Arévalo-Herrera M, Herrera S, Plasmodium vivax gametocyte infectivity in submicroscopic infections. Malar J. 2016;In press.
48. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG, Research Electronic Data Capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support. Journal of Biomedical Informatics. 2009;42(2):377–81. doi: 10.1016/j.jbi.2008.08.01018929686; PubMed Central PMCID: PMC2700030.
49. Peyron F, Burdin N, Ringwald P, Vuillez J, Rousset F, Banchereau J, High levels of circulating IL-10 in human malaria. Clinical & Experimental Immunology. 1994;95(2):300–3.
50. Abeles SR, Chuquiyauri R, Tong C, Vinetz JM, Human host-derived cytokines associated with Plasmodium vivax transmission from acute malaria patients to Anopheles darlingi mosquitoes in the Peruvian Amazon. The American journal of tropical medicine and hygiene. 2013;88(6):1130–7. doi: 10.4269/ajtmh.12-075223478585
51. Nacer A, Walker K, Hurd H, Localisation of laminin within Plasmodium berghei oocysts and the midgut epithelial cells of Anopheles stephensi. Parasit Vectors. 2008;1:33. doi: 10.1186/1756-3305-1-3318808667